60.65
2.59%
-1.61
시간 외 거래:
60.65
전일 마감가:
$62.26
열려 있는:
$62.34
하루 거래량:
327.08K
시가총액:
$2.38B
수익:
$101.10M
순이익/손실:
$-44.50M
주가수익비율:
-30.48
EPS:
-1.99
순현금흐름:
$-39.17M
1주 성능:
+2.26%
1개월 성능:
+14.80%
6개월 성능:
+120.31%
1년 성능:
+153.13%
RxSight Inc Stock (RXST) Company Profile
명칭
RxSight Inc
전화
949-521-7830
주소
100 Columbia, Suite 120, Aliso Viejo
RxSight Inc Stock (RXST) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2023-12-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
2023-12-12 | 개시 | Stifel | Buy |
2023-12-04 | 개시 | Morgan Stanley | Overweight |
2023-04-13 | 개시 | Oppenheimer | Outperform |
2022-12-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
2022-04-08 | 개시 | Needham | Buy |
모두보기
RxSight Inc 주식(RXST)의 최신 뉴스
RxSight (NASDAQ:RXST) Stock Price Down 3.1% - MarketBeat
MarketBeat
Midday Stock Roundup: Eledon, Avid Bioservices Up - Orange County Business Journal
Orange County Business Journal
Stifel Initiates Coverage of RxSight (RXST) with Buy Recommendation - MSN
MSN
Midday Stock Roundup: Eledon Pharma Shares Double - Orange County Business Journal
Orange County Business Journal
RxSight Inc Inc. (RXST) Price Performance: The Role of Supply and Demand - The InvestChronicle
The InvestChronicle
Investing in RxSight Inc (RXST) Is Getting More Attractive – Knox Daily - Knox Daily
Knox Daily
RxSight Inc (RXST) 재무 분석
RxSight Inc (RXST) 매출 2024
RXST은 2024-03-31 종료 분기에 대해 매출(지난 12개월)이 101.10M 달러로 보고했으며, 전년대비 +75.67% 상승했습니다.
RxSight Inc (RXST) 순이익 2024
RXST은 2024-03-31 종료 분기에 대해 순이익(지난 12개월)이 -44.50M 달러로 보고했으며, 전년대비 +28.66% 증가했습니다.
RxSight Inc (RXST) 현금흐름 2024
2024-03-31 종료 분기에 RXST은 현금흐름(지난 12개월)으로 -39.17M 달러를 기록했으며, 전년 대비 +39.17% 증가했습니다.
RxSight Inc (RXST) 주당 순이익 2024
RXST이 보고한 2024-03-31 종료 분기의 주당 순이익(지난 12개월)은 -1.25달러이며, 전년 대비 +43.18% 성장했습니다.
RxSight Inc 주식 (RXST) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Kurtz Ronald M MD | President & CEO |
May 03 '24 |
Sale |
60.15 |
40,000 |
2,405,872 |
764,610 |
Thunen Shelley B | Chief Financial Officer |
May 01 '24 |
Option Exercise |
15.60 |
10,247 |
159,836 |
23,938 |
Thunen Shelley B | Chief Financial Officer |
May 01 '24 |
Sale |
52.69 |
10,000 |
526,913 |
13,938 |
Thunen Shelley B | Chief Financial Officer |
Apr 01 '24 |
Sale |
49.90 |
20,000 |
997,946 |
8,402 |
Thunen Shelley B | Chief Financial Officer |
Mar 01 '24 |
Option Exercise |
15.60 |
10,000 |
155,983 |
23,691 |
Thunen Shelley B | Chief Financial Officer |
Mar 01 '24 |
Sale |
56.37 |
10,000 |
563,726 |
13,691 |
Goldshleger Ilya | Chief Operating Officer |
Feb 16 '24 |
Option Exercise |
23.04 |
10,000 |
230,400 |
36,475 |
Goldshleger Ilya | Chief Operating Officer |
Feb 16 '24 |
Sale |
55.50 |
10,000 |
555,000 |
26,475 |
Goldshleger Ilya | Chief Operating Officer |
Feb 15 '24 |
Option Exercise |
23.04 |
10,000 |
230,400 |
36,475 |
Goldshleger Ilya | Chief Operating Officer |
Feb 15 '24 |
Sale |
53.50 |
10,000 |
535,000 |
26,475 |
자본화:
|
볼륨(24시간):